Kiesel Law LLP is investigating losses resulting from investments in UBS’s Yield Enhancement Strategy (“YES”), ETRACS and ETNs (Exchange Traded Notes).
YES was marketed as a safe product with which to enhance the income on your investments. UBS used the term “downside protection” to highlight its safety and represented that YES would provide investors with modest income at minimal risk.
However, it appears YES had significant risk factors which led to large losses. All financial advisors including those at UBS have an obligation to recommend only investment strategies that are appropriate for their clients’ needs and objectives and to properly explain the downsides of any investment. Some experts have concluded that YES and the risky “Iron Condor” options strategy used by UBS was not a safe method to generate income nor was it appropriate to use investors’ assets as collateral in a margin account. YES losses may exceed $750 million in total and if you sustained losses, we would like speak with you for a no fee consultation.
Similarly, with UBS ETRACS and ETNs, these were debt securities tied to an index. Many of those indexes have been hit very hard by COVID-19 and the economic slowdown. Further, some ETRACS and ETNs were additionally leveraged meaning that they would go up, or down, at an even faster rate. Compounding these issues, certain of the ETRACS and ETNs were the subject of mandatory redemptions when the market turned making recovery from a steep loss impossible. Again, these types of investments are not appropriate for all investors and if you sustained losses, we would like to hear from you.
Kiesel Law LLP has obtained verdicts and settlements of over $2 billion dollars for its clients. We believe that YES losses may be recoverable via a FINRA arbitration claim.
If you have losses from the UBS Yield Enhancement Strategy, please contact us for a free evaluation to discuss your options for recovery. No recovery, no fee.
We can be reached at 310-854-4444